Skip to main content

BiomX Inc. (PHGE) Stock Forecast

Data as of May 9, 2026

Healthcare · Current price $0.63 (+1.74%)

Consensus Target
$2.00
Upside
+5932.7%
Analysts
3
Rating
Buy(2.33)

Price Target Range

Low $2.00High $2.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

PHGE vs Sector & Market

MetricPHGEHealthcare AvgLarge Cap Avg
Analyst Rating2.332.242.41
Analyst Count3819
Target Upside+5932.7%+1703.6%+16.4%
P/E Ratio-1.663.3027.60

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$24M$24M$24M2
2027-12-31$57M$57M$57M2
2028-12-31$14M$14M$14M2
2029-12-31$20M$20M$20M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-12.23$-12.23$-12.231
2027-12-31$-12.98$-12.98$-12.981
2028-12-31$-20.52$-12.54$-4.572
2029-12-31$-31.54$-31.54$-31.541

Frequently Asked Questions

What is the analyst consensus for PHGE?

The consensus among 3 analysts covering BiomX Inc. (PHGE) is Buy with an average price target of $2.00.

What is the highest price target for PHGE?

The highest analyst price target for PHGE is $2.00.

What is the lowest price target for PHGE?

The lowest analyst price target for PHGE is $2.00.

How many analysts cover PHGE?

3 analysts have issued ratings for BiomX Inc. in the past 12 months.

Is PHGE a buy or sell right now?

Based on 3 analyst ratings, PHGE has a consensus rating of Buy (2.33/5) with a +5932.7% upside to the consensus target of $2.00.

What are the earnings estimates for PHGE?

Analysts estimate PHGE will report EPS of $-12.23 for the period ending 2026-12-31, with revenue estimated at $24M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.